COMPLEX TREATMENT OF COMPLICATED FORMS OF ERYSIPELAS

Summary. Objectives: to analyze the immediate results of the complex treatment of complicated forms of erysipelas. Methods: A retrospective analysis of the immediate results of complex treatment of 67 patients with complicated forms of erysipelas was conducted. There were 29 (43.3%) men, 38 (56.7...

Full description

Saved in:
Bibliographic Details
Main Authors: V.O. Syplyviy, V.V. Dotsenko, D.V. Ievtushenko, O.V. Ievtushenko, O.V. Kolotilov
Format: Article
Language:English
Published: Zaporizhzhia State Medical and Pharmaceutical University 2022-12-01
Series:Сучасні медичні технології
Subjects:
Online Access:https://zmapo-journal.com/index.php/journal/article/view/243
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841562928021504000
author V.O. Syplyviy
V.V. Dotsenko
D.V. Ievtushenko
O.V. Ievtushenko
O.V. Kolotilov
author_facet V.O. Syplyviy
V.V. Dotsenko
D.V. Ievtushenko
O.V. Ievtushenko
O.V. Kolotilov
author_sort V.O. Syplyviy
collection DOAJ
description Summary. Objectives: to analyze the immediate results of the complex treatment of complicated forms of erysipelas. Methods: A retrospective analysis of the immediate results of complex treatment of 67 patients with complicated forms of erysipelas was conducted. There were 29 (43.3%) men, 38 (56.7%) women. The average age was 65.1 years. Results: The duration of symptoms of the disease before hospitalization varied from 3 to 14 days. The erythematous form of erysipelas was found in 7 (10.5%), erythematous-hemorrhagic – in 14 (20.9%), erythematous-bullous – in 21 (31.3%), bullous-hemorrhagic – in 25 (37.3 %). According to the localization, erysipelas of the head was found in 5 (7.5%), upper limbs - in 3 (4.5%), lower limbs - in 59 (88%). Primary erysipelas was present in 39 (58.2%), recurrent – in 28 (41.8%). In the picture of peripheral blood, leukocytosis is determined with a shift of the leukocyte blood formula to the left. The level of C-reactive protein is 18 - 100 times higher than the upper limit of normal. According to the results of cultures of scrapings of affected tissues, the dominance of Staphyloccus haemolyticus in associations with other gram-positive and gram-negative microorganisms was revealed. High polyresistance of Staphyloccus haemolyticus strains to antibacterial drugs with preservation sensitivity to Clindamycin, Vancomycin, Linezolid, and Teicoplatin was inserted. Conclusions: Complicated forms of erysipelas are found in 89.5% of patients who are being treated in the surgical department for erysipelas. The most frequent localization is erysipelas of the lower limbs, which is found in 88%. Staphylococcus haemolyticus is dominant among the causative agents of erysipelas in various associations with other gram-positive and gram-negative microorganisms. A high polyresistance of Staphylococcus haemolyticus strains to antibacterial drugs is determined, while sensitivity to clindamycin, vancomycin, linezolid, and teicoplanin is preserved. Treatment of erysipelas is complex, including antibacterial therapy, surgical treatment of complications, local treatment of wounds, drug corrective therapy of concomitant chronic pathology.
format Article
id doaj-art-7669605441ec4853a77651499c1f1cca
institution Kabale University
issn 2072-9367
language English
publishDate 2022-12-01
publisher Zaporizhzhia State Medical and Pharmaceutical University
record_format Article
series Сучасні медичні технології
spelling doaj-art-7669605441ec4853a77651499c1f1cca2025-01-03T00:38:00ZengZaporizhzhia State Medical and Pharmaceutical UniversityСучасні медичні технології2072-93672022-12-014(55)515510.34287/MMT.4(55).2022.9243COMPLEX TREATMENT OF COMPLICATED FORMS OF ERYSIPELASV.O. Syplyviy0V.V. Dotsenko1D.V. Ievtushenko2O.V. Ievtushenko3O.V. Kolotilov4Kharkiv National Medical University, Kharkiv, UkraineKharkiv National Medical University, Kharkiv, UkraineKharkiv National Medical University, Kharkiv, UkraineKharkiv National Medical University, Kharkiv, UkraineKharkiv National Medical University, Kharkiv, UkraineSummary. Objectives: to analyze the immediate results of the complex treatment of complicated forms of erysipelas. Methods: A retrospective analysis of the immediate results of complex treatment of 67 patients with complicated forms of erysipelas was conducted. There were 29 (43.3%) men, 38 (56.7%) women. The average age was 65.1 years. Results: The duration of symptoms of the disease before hospitalization varied from 3 to 14 days. The erythematous form of erysipelas was found in 7 (10.5%), erythematous-hemorrhagic – in 14 (20.9%), erythematous-bullous – in 21 (31.3%), bullous-hemorrhagic – in 25 (37.3 %). According to the localization, erysipelas of the head was found in 5 (7.5%), upper limbs - in 3 (4.5%), lower limbs - in 59 (88%). Primary erysipelas was present in 39 (58.2%), recurrent – in 28 (41.8%). In the picture of peripheral blood, leukocytosis is determined with a shift of the leukocyte blood formula to the left. The level of C-reactive protein is 18 - 100 times higher than the upper limit of normal. According to the results of cultures of scrapings of affected tissues, the dominance of Staphyloccus haemolyticus in associations with other gram-positive and gram-negative microorganisms was revealed. High polyresistance of Staphyloccus haemolyticus strains to antibacterial drugs with preservation sensitivity to Clindamycin, Vancomycin, Linezolid, and Teicoplatin was inserted. Conclusions: Complicated forms of erysipelas are found in 89.5% of patients who are being treated in the surgical department for erysipelas. The most frequent localization is erysipelas of the lower limbs, which is found in 88%. Staphylococcus haemolyticus is dominant among the causative agents of erysipelas in various associations with other gram-positive and gram-negative microorganisms. A high polyresistance of Staphylococcus haemolyticus strains to antibacterial drugs is determined, while sensitivity to clindamycin, vancomycin, linezolid, and teicoplanin is preserved. Treatment of erysipelas is complex, including antibacterial therapy, surgical treatment of complications, local treatment of wounds, drug corrective therapy of concomitant chronic pathology.https://zmapo-journal.com/index.php/journal/article/view/243erysipelascomplicated formscomplex treatment
spellingShingle V.O. Syplyviy
V.V. Dotsenko
D.V. Ievtushenko
O.V. Ievtushenko
O.V. Kolotilov
COMPLEX TREATMENT OF COMPLICATED FORMS OF ERYSIPELAS
Сучасні медичні технології
erysipelas
complicated forms
complex treatment
title COMPLEX TREATMENT OF COMPLICATED FORMS OF ERYSIPELAS
title_full COMPLEX TREATMENT OF COMPLICATED FORMS OF ERYSIPELAS
title_fullStr COMPLEX TREATMENT OF COMPLICATED FORMS OF ERYSIPELAS
title_full_unstemmed COMPLEX TREATMENT OF COMPLICATED FORMS OF ERYSIPELAS
title_short COMPLEX TREATMENT OF COMPLICATED FORMS OF ERYSIPELAS
title_sort complex treatment of complicated forms of erysipelas
topic erysipelas
complicated forms
complex treatment
url https://zmapo-journal.com/index.php/journal/article/view/243
work_keys_str_mv AT vosyplyviy complextreatmentofcomplicatedformsoferysipelas
AT vvdotsenko complextreatmentofcomplicatedformsoferysipelas
AT dvievtushenko complextreatmentofcomplicatedformsoferysipelas
AT ovievtushenko complextreatmentofcomplicatedformsoferysipelas
AT ovkolotilov complextreatmentofcomplicatedformsoferysipelas